AI is ‘rapidly transforming’ cyber security risk, Five Eyes agencies warn
Representatives of the leading Five Eyes cyber security agencies have warned that governments and businesses need to act swiftly i...
ANT61 announces delivery of Beacon hardware for US Space Force flight in 2027
Infrastructure resilience company ANT61 has announced delivery of its Beacon hardware to a US defence systems integrator. ...
Sensofusion announces tactical drone factory shipping container to build 50 drones per day
Finnish defence company Sensofusion has announced a ‘tactical drone factory’ shipping container designed to build 50 intercept...
US naval power at stretching point: US and Iran deal points to security challenge for Australia
Australia’s naval leaders will be watching the final terms of any US-Iran peace deal closely because reopening the Strait of Hor...

JP2060 Phase 3 contender sets sights on human health research

Joint-capabilities
|
By: Reporter
monash leidos mou

Leidos Australia has signed a memorandum of understanding (MoU) with Monash University to collaborate on research and development at the Monash Institute of Medical Engineering (MIME).

Leidos Australia has signed a memorandum of understanding (MoU) with Monash University to collaborate on research and development at the Monash Institute of Medical Engineering (MIME).

MIME fosters and co-ordinates translational medtech research across Monash University faculties, partner hospitals and collaborating medical research institutions. The clinician-led research programs focus on major clinical and health system needs, and integrate expertise from across engineering, information technology, science, biomedical and clinical research to develop new devices, diagnostics, therapeutics, delivery systems and clinical tools.

The MoU, signed by the director of MIME, Professor Jeffrey Rosenfeld AM, OBE, and Leidos Australia technical director Dan Brewer, will focus on the development of innovative technologies and solutions to address human health problems.

 
 

"It will foster the development of new technology and IT solutions for human health problems," said Professor Rosenfeld.

"University-industry collaboration is an important goal to create new opportunities for Australian innovation to reach the marketplace."

Brewer added, “Health is a key area for Leidos globally and as we continue to grow domestically, we will be looking to further develop our range of capabilities in this area."

The MoU will also see Leidos Australia and the MIME collaborate on future R&D with the initial contribution including the funding of a PhD research student.

Leidos is one of the primes tendering for Defence's Deployable Health Capability (JP2060 Phase 3), which aims to introduce an entire system (mission system), inclusive of all medical and dental equipment (a turn key solution) and designed to operate as an integrated capability.

The company also signed another MoU with the University of New South Wales to collaborate on research into the development of force protection and biological security for the Australian Defence Force.

Want to see more stories from trusted news sources?
Make Defence Connect a preferred news source on Google.
Click here to add Defence Connect as a preferred news source.

Tags: